Table 2. Patient and disease characteristics.
| Characteristic | Value |
|---|---|
| Total patients | 42 |
| Total lesions evaluated | 81 |
| Age at treatment of each lesion (years) | 65 [39–87] |
| Gender, n [%] | |
| Male | 21 [50] |
| Female | 21 [50] |
| Primary tumor location, n (%) | |
| Anal | 1 (2.4) |
| Bladder | 1 (2.4) |
| Breast | 3 (7.1) |
| Cervical | 1 (2.4) |
| Colon | 18 (42.9) |
| Lung | 7 (16.7) |
| Pancreas | 2 (4.8) |
| Peritoneal | 1 (2.4) |
| Prostate | 1 (2.4) |
| Rectal | 1 (2.4) |
| Renal | 2 (4.8) |
| Stomach | 1 (2.4) |
| Uterine | 3 (7.1) |
| Presence of extrahepatic disease at treatment of each lesion, n (%) | |
| Yes | 12 (14.8) |
| No | 65 (80.2) |
| Time since primary diagnosis (months) | 26 [6–216] |
| Primary tumor control, n [%] | |
| Yes | 42 [100] |
| No | 0 |
| Karnofsky performance score | 90% [70–100%] |
Characteristics of each patient undergoing treatment with SBRT as well as the status of their primary disease were ascertained from the patient registry database.